This page includes the latest FDA filings for Eyepoint Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NASDAQ | EYPT | DUNS 008225658 |
Device Company | Device | Date |
---|---|---|
EyePoint Pharmaceuticals, Inc | Prescription Medication | 2023-12-23 |
EyePoint Pharmaceuticals, Inc | Prescription Medication | 2023-10-17 |
EyePoint Pharmaceuticals, Inc | Prescription Medication | 2022-12-23 |
EyePoint Pharmaceuticals, Inc | Prescription Medication | 2021-12-21 |
EyePoint Pharmaceuticals, Inc | Prescription Medication | 2021-12-15 |
EyePoint Pharmaceuticals, Inc | Prescription Medication | 2020-09-11 |
EyePoint Pharmaceuticals, Inc | Prescription Medication | 2019-02-15 |
EyePoint Pharmaceuticals, Inc | YUTIQ | 2018-10-12 |
NCAGE Code | 89D47 | EYEPOINT PHARMACEUTICALS, INC. |
CAGE Code | 89D47 | EYEPOINT PHARMACEUTICALS, INC. |
SEC | 0001314102 | EyePoint Pharmaceuticals, Inc. of DELAWARE |